Streetbeat News

Equity Actions

BIOR

Biora Therapeutics has announced a reverse stock split at a 10:1 ratio, effective October 18. This corporate action is likely to impact the stock's trading dynamics and investor perception.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:05 pm

JPM

JPMorgan CEO Jamie Dimon stated that the company will continue its modest pace of share repurchases, citing slightly inflated market levels. However, the company reserves the right to adjust its buyback strategy at any time.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 10:58 am

STLA

Stellantis CEO Carlos Tavares plans to retire in 2026, prompting strategic leadership changes and a formal process to identify his successor, led by a Special Committee chaired by John Elkann.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 8:04 am

RDACU

Rising Dragon Acquisition Corp. has priced its $50M IPO, offering 5M units at $10 each. The units will be listed on NASDAQ under the ticker 'RDACU' starting October 11, 2024. Each unit includes one ordinary share and one right, with each right converting to one-tenth of a share upon a business combination.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 7:45 am

UPB

Upstream Bio has priced its upsized IPO at $255 million, offering 15 million common shares at $17 each. The shares will trade on Nasdaq under the symbol 'UPB' starting October 11, 2024, with the offering expected to close on October 15, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 7:22 am

IMTX

Immatics has announced a public offering of 16.25 million common shares priced at $9.25 per share, aiming to raise $150 million.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:24 am

CBLL

CeriBell has announced an upsized IPO, pricing 10,606,060 common shares at $17 each, aiming to raise approximately $180.3 million. The shares will trade on Nasdaq under the ticker 'CBLL' starting October 11, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:47 am

ARKG

ARKK

MRNA

Cathie Wood's Ark Invest sold over $9M in Moderna stock, despite the company's post-COVID plans. The sale involved ARK Genomic Revolution ETF and ARK Innovation ETF. Moderna's stock is under scrutiny with mixed analyst sentiments and a revised financial plan.

Portfolio Pulse from Benzinga Neuro

October 11, 2024 | 2:14 am

JTAI

Jet.AI Inc. (NASDAQ:JTAI) shares fell after announcing a direct offering of 26.6 million shares at nine cents each, raising approximately $2.4 million. The stock dropped 11.77% during regular trading but rose 8.57% after-hours.

Portfolio Pulse from Erica Kollmann

October 10, 2024 | 9:08 pm

ATR

AptarGroup has announced a new authorization to repurchase up to $500 million of its common stock, replacing all previous authorizations. The company may buy back shares through various methods, depending on market conditions. Additionally, AptarGroup declared a quarterly cash dividend of $0.45 per share, payable on November 14, 2024, to shareholders of record as of October 24, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 9:01 pm